Get an alert when BIOMARIN (U.K.) LTD. files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-01-06 (in 8mo)

Last made up 2025-12-23

Watchouts

None on the register

Cash

£18M

+102.7% vs 2023

Net assets

£22M

+30.9% vs 2023

Employees

131

+3.1% vs 2023

Profit before tax

£7M

+1.2% vs 2023

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £71,298,000£79,709,000
Operating profit £5,303,000£6,014,000
Profit before tax £6,941,000£7,021,000
Net profit £4,296,000£5,246,000
Cash £8,829,000£17,893,000
Total assets less current liabilities £18,060,000£22,705,000
Net assets £16,974,000£22,220,000
Equity £16,974,000£22,220,000
Average employees 127131
Wages £20,731,000£24,943,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 7.4%7.5%
Net margin 6.0%6.6%
Return on capital employed 29.4%26.5%
Gearing (liabilities / total assets) 54.0%37.3%
Current ratio 1.71x2.50x
Interest cover 189.39x20.95x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101 Reduced Disclosure Framework
Reporting scope
Standalone (parent only)
Auditor
KPMG
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“After reviewing the Company's forecasts and projections, the Directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

5 active · 8 resigned

Name Role Appointed Born Nationality
DAVIS, George Eric Secretary 2009-12-23
DAVIS, George Eric Director 2009-12-23 Feb 1971 American
KEOGH, Brian Director 2020-03-24 Jun 1971 Irish
MORGAN, Chay Bradwen Director 2016-06-01 Aug 1968 British
MORRIS, Richard Gideon Director 2014-03-31 Mar 1973 British
Show 8 resigned officers
Name Role Appointed Resigned
ILETT, John Edward Secretary 2010-02-03 2010-05-31
ASELAGE, Stephen Joseph Director 2010-02-03 2012-10-15
BAUMANN, Astrid Irmgard Elfriede Director 2018-11-09 2022-12-05
GLASS, Steven John Director 2009-12-23 2010-02-03
ILETT, John Edward Director 2010-02-03 2010-05-31
LENNERTZ, James Karin Director 2022-12-05 2024-10-08
LENNERTZ JR, James Karin Director 2012-09-27 2014-03-31
SHANAHAN, John Joseph Director 2018-04-26 2020-03-31

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Biomarin Pharmaceutical Inc. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-07-28 Active

Filing timeline

Last 20 of 65 total filings

Date Type Category Description
2025-12-23 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-09-29 AA accounts Accounts with accounts type full
2024-12-23 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-11-06 CH01 officers Change person director company with change date PDF
2024-11-06 CH01 officers Change person director company with change date PDF
2024-10-09 TM01 officers Termination director company with name termination date PDF
2024-07-29 AAMD accounts Accounts amended with accounts type full
2024-07-16 AA accounts Accounts with accounts type full
2023-12-27 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-12-19 AD02 address Change sail address company with old address new address PDF
2023-10-17 AA accounts Accounts with accounts type full
2023-02-07 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-02-07 CH01 officers Change person director company with change date PDF
2022-12-16 TM01 officers Termination director company with name termination date PDF
2022-12-05 AP01 officers Appoint person director company with name date PDF
2022-07-25 AA accounts Accounts with accounts type full
2022-01-20 CH01 officers Change person director company with change date PDF
2022-01-20 CH01 officers Change person director company with change date PDF
2022-01-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-07-09 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page